Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer

BACKGROUND: Many current therapies for metastatic castration-resistant prostate cancer (mCRPC) are aimed at AR signaling; however, resistance to these therapies is inevitable. To personalize CRPC therapy in an individual with clinical progression despite maximal AR signaling blockade, it is importan...

Descripción completa

Detalles Bibliográficos
Autores principales: Reyes, Edwin E, VanderWeele, David J, Isikbay, Masis, Duggan, Ryan, Campanile, Alexa, Stadler, Walter M, Vander Griend, Donald J, Szmulewitz, Russell Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252013/
https://www.ncbi.nlm.nih.gov/pubmed/25424879
http://dx.doi.org/10.1186/s12967-014-0313-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252013/
https://www.ncbi.nlm.nih.gov/pubmed/25424879
http://dx.doi.org/10.1186/s12967-014-0313-z

Ejemplares similares